Literature DB >> 16731600

My approach to the diagnosis of mesothelial lesions.

K J Butnor1.   

Abstract

Mesothelial lesions pose considerable diagnostic challenges not only because benign tumours, reactive proliferations and malignant mesothelioma can mimic one another, but also because the morphological patterns displayed by malignant mesothelioma can simulate a variety of epithelial and non-epithelial malignancies. Immunohistochemical markers can aid in distinguishing epithelioid malignant mesothelioma from metastatic adenocarcinoma, but because no single marker reliably separates all cases, a panel of stains is recommended. Immunohistochemical studies are of more limited value in sarcomatoid malignant mesothelioma, and other features often play an essential role. The separation of reactive mesothelial proliferations from malignant mesothelioma on small biopsy can be quite difficult, as distinguishing features, such as stromal invasion, often cannot be adequately assessed. In adequately sampled lesions, however, the distinction between malignant mesothelioma, benign mesothelial proliferations and other tumours can be achieved in most cases by using a carefully integrated approach that incorporates clinical and radiographic data, immunohistochemical studies and, in selected cases, histochemical and ultrastructural techniques.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731600      PMCID: PMC1860395          DOI: 10.1136/jcp.2005.029652

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  84 in total

1.  Value of thrombomodulin immunostaining in the diagnosis of mesothelioma.

Authors:  N G Ordóñez
Journal:  Histopathology       Date:  1997-07       Impact factor: 5.087

2.  Lesions described as nodular mesothelial hyperplasia are primarily composed of histiocytes.

Authors:  N G Ordóñez; J Y Ro; A G Ayala
Journal:  Am J Surg Pathol       Date:  1998-03       Impact factor: 6.394

3.  TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung.

Authors:  C Di Loreto; F Puglisi; V Di Lauro; G Damante; C A Beltrami
Journal:  Cancer Lett       Date:  1998-02-13       Impact factor: 8.679

4.  E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma.

Authors:  M P Leers; M M Aarts; P H Theunissen
Journal:  Histopathology       Date:  1998-03       Impact factor: 5.087

5.  The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies.

Authors:  N G Ordóñez
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

6.  The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval.

Authors:  J R Riera; C Astengo-Osuna; J A Longmate; H Battifora
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

7.  Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.

Authors:  N G Ordóñez
Journal:  Hum Pathol       Date:  1998-02       Impact factor: 3.466

8.  The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.

Authors:  K D Wolanski; D Whitaker; K B Shilkin; D W Henderson
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

Review 9.  Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.

Authors:  N G Ordóñez
Journal:  Am J Clin Pathol       Date:  1998-01       Impact factor: 2.493

10.  A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours.

Authors:  M D Garcia-Prats; C Ballestin; T Sotelo; A Lopez-Encuentra; J I Mayordomo
Journal:  Histopathology       Date:  1998-05       Impact factor: 5.087

View more
  9 in total

1.  Coarse pleural calcification in a mesothelioma patient raises the possibility of a rare tumour subtype: osteoblastic sarcomatoid mesothelioma.

Authors:  A M Mortimer; J Rowlands; P Murphy
Journal:  Br J Radiol       Date:  2011-05       Impact factor: 3.039

2.  Evaluation of the sensitivity and specificity of immunohistochemical markers in the differential diagnosis of effusion cytology.

Authors:  Zahraa Mohammed Yahya; Hussam Hasson Ali; Haider Ghazi Hussein
Journal:  Oman Med J       Date:  2013-11

3.  A new electrocautery pleural biopsy technique using an insulated-tip diathermic knife during semirigid pleuroscopy.

Authors:  Shinji Sasada; Kunimitsu Kawahara; Yoko Kusunoki; Norio Okamoto; Teruo Iwasaki; Hidekazu Suzuki; Masashi Kobayashi; Tomonori Hirashima; Kaoru Matsui; Mitsunori Ohta; Teruomi Miyazawa
Journal:  Surg Endosc       Date:  2009-01-01       Impact factor: 4.584

4.  Desmoplastic malignant mesothelioma of the pericardium: Description of a case and review of the literature.

Authors:  Antonello Nicolini; Alessandro Perazzo; Sergio Lanata
Journal:  Lung India       Date:  2011-07

5.  First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.

Authors:  Markus W Löffler; Julia Steinhilber; Franz J Hilke; Sebastian P Haen; Hans Bösmüller; Ivonne-Aidee Montes-Mojarro; Irina Bonzheim; Antje Stäbler; Ulrike Faust; Ute Grasshoff; Ingmar Königsrainer; Hans-Georg Rammensee; Lothar Kanz; Alfred Königsrainer; Stefan Beckert; Olaf Riess; Christopher Schroeder
Journal:  BMC Med Genet       Date:  2018-08-15       Impact factor: 2.103

6.  CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.

Authors:  Eeva Kettunen; Sauli Savukoski; Kaisa Salmenkivi; Tom Böhling; Esa Vanhala; Eeva Kuosma; Sisko Anttila; Henrik Wolff
Journal:  BMC Cancer       Date:  2019-05-28       Impact factor: 4.430

7.  Gastroblastoma in Adulthood-A Rarity among Rare Cancers-A Case Report and Review of the Literature.

Authors:  Giovanni Centonze; Alessandro Mangogna; Tiziana Salviato; Beatrice Belmonte; Laura Cattaneo; Melissa Anna Teresa Monica; Giovanna Garzone; Cecilia Brambilla; Alessio Pellegrinelli; Flavia Melotti; Adele Testi; Valentina Monti; Ketevani Kankava; Patrizia Gasparini; Gianpaolo Dagrada; Vincenzo Mazzaferro; Christian Cotsoglou; Paola Collini; Giancarlo Pruneri; Massimo Milione
Journal:  Case Rep Pathol       Date:  2019-11-28

8.  Malignant peritoneal mesothelioma with a sarcomatoid growth pattern and signet-ring-like structure in a female f344 rat.

Authors:  Aya Ohnuma-Koyama; Toshinori Yoshida; Naofumi Takahashi; Satoshi Akema; Yukiko Takeuchi-Kashimoto; Maki Kuwahara; Mika Nagaike; Kosei Inui; Nobuaki Nakashima; Takanori Harada
Journal:  J Toxicol Pathol       Date:  2013-07-10       Impact factor: 1.628

9.  Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis.

Authors:  Bo Wang; Diandian Li; Xuemei Ou; Qun Yi; Yulin Feng
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.